https://www.businesswire.com/news/home/20260305082171/en/NeuroPace-to-Present-at-the-Leerink-Global-Healthcare-Conference
NeuroPace to Present at the Leerink Global Healthcare Conference
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its managemen...
at theglobal healthcarepresentconference
https://www.businesswire.com/news/home/20260220564571/en/NeuroPace-to-Report-Fourth-Quarter-2025-Financial-Results-on-March-3-2026
NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report fin...
to reportfourth quarter
https://www.neuropace.com/
NeuroPace | A Smarter Way to Treat Epilepsy
Mar 23, 2023 - The NeuroPace RNS System is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides...
way tosmartertreatepilepsy
https://www.nasdaq.com/market-activity/stocks/npce/insider-activity
Neuropace, Inc. Common Stock (NPCE) Insider Activity | Nasdaq
Find the latest information on Neuropace, Inc. Common Stock (NPCE) insider activity and insider shares traded to make sound investments with Nasdaq.com.
common stockinsider activityincnasdaq